ASP0367

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ASP0367, covering 2024-10-21 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy [Phase 2]